Menarini Raunaq Pharma Limited(Punjab To Delhi)

Menarini Raunaq Pharma Limited(Punjab To Delhi)

Founded in 1994 headquartered in Delhi, India.
1994 | West Delhi, Delhi (India) | Merged

Last Updated:

April 07, 2024
HomeCompanyMenarini Raunaq Pharma Limited(Punjab To Delhi)

Who are the key members and board of directors at Menarini Raunaq PharmaPunjab To Delhi)?

Executive Team (1)

NameDesignationAppointment DateStatus
Harish IyerCompany Secretary17-May-2013Current

Board Members(3)

NameDesignationAppointment DateStatus
Anandh Balasundaram In Additional Director 19-Jan-2015Current
Uwe Kronenberg De Director 30-Jun-2001Current
Attilio Sebastio It Director 30-Jun-2001Current

Financial Performance and Corporate Structure Insights of Menarini Raunaq PharmaPunjab To Delhi).

Enhance accessibility to Menarini Raunaq PharmaPunjab To Delhi)'s financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
Profit or Loss
Net Worth
EBITDA

Related Corporates (Common Directorship)

Charges (Loans)

Charges

There are no open charges registered against the company as per our records.

How Many Employees Work at Menarini Raunaq PharmaPunjab To Delhi)?

Unlock and access historical data on people associated with Menarini Raunaq PharmaPunjab To Delhi), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Menarini Raunaq PharmaPunjab To Delhi)

Recent activity within the organization

  • Director Appointment

    Anandh Balasundaram was appointed as a Additional Director was appointed as a Additional Director on 19 Jan 2015 & has been associated with this company since 9 years 11 months .

    19 Jan 2015

  • Annual General Meeting

    Menarini Raunaq Pharma Limited(Punjab To Delhi) last Annual general meeting of members was held on 23 Jun 2014 as per latest MCA records.

    23 Jun 2014

  • Balance Sheet

    Menarini Raunaq Pharma Limited(Punjab To Delhi) has filed its annual Financial statements for the year ended 31 Dec 2013 with Roc Delhi.

    31 Dec 2013

  • Director Appointment

    Harish Dattatreyan Iyer was appointed as a Company Secretary was appointed as a Company Secretary on 17 May 2013 & has been associated with this company since 11 years 7 months .

    17 May 2013

  • Director Appointment

    Uwe Kronenberg was appointed as a Director was appointed as a Director on 30 Jun 2001 & has been associated with this company since 23 years 5 months .

    30 Jun 2001

  • Director Appointment

    Attilio Sebastio was appointed as a Director was appointed as a Director on 30 Jun 2001 & has been associated with this company since 23 years 5 months .

    30 Jun 2001

Frequently asked questions

  • Menarini Raunaq Pharma Limited(Punjab To Delhi) was incorporated on 05 Sep 1994.

  • The authorized share capital of Menarini Raunaq Pharma Limited(Punjab To Delhi) is ₹ 65.00 Cr and paid-up capital is ₹ 63.69 Cr.

  • Currently 4 directors are associated with Menarini Raunaq Pharma Limited(Punjab To Delhi).

    • Uwe Kronenberg
    • Anandh Balasundaram
    • Harish Dattatreyan Iyer
    • Attilio Sebastio
  • As per Ministry of Corporate Affairs (Mca), the registered address of Menarini Raunaq Pharma Limited(Punjab To Delhi) is B-16 First Floor B-1 Community Center, B-Block Janakpuri, New Delhi, India, 110058.

  • The corporate identification number (CIN) of Menarini Raunaq Pharma Limited(Punjab To Delhi) is U74899DL1994PLC104559 and the company number is 104559 as per Ministry of Corporate Affairs (MCA).

  • The most recent Balance Sheet for Menarini Raunaq Pharma Limited(Punjab To Delhi) was filed with the ROC on 31 Dec 2013.